Simple urine test could show if lung cancer immunotherapy is working
NCT ID NCT05928299
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at 150 people with advanced non-small cell lung cancer to see if proteins and metabolites in blood and urine could help monitor how well immunotherapy is working. Researchers used mass spectrometry to measure these markers before, during, and after treatment. The goal was to find patterns that might predict treatment response or side effects, not to test a new drug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood or urine test to help doctors know if immunotherapy is working for lung cancer patients.
- What could go wrong
- This was a small, completed study that only looked for markers—it did not test a new treatment. The findings may not lead to a widely usable test.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanfang hospital
Guangzhou, Guangdong, 510400, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Breathing tube-free lung surgery tested for patients with fragile lungs
- Can standard cancer treatment wake up the immune system? a study investigates.
- Quitlines may double as lung cancer screening boosters
- A mobile app aims to turn health awareness into action — a trial puts it to the test
- Text messages and chatbots may help catch lung cancer earlier in underserved communities
- Shorter radiation course may reduce side effects for lung cancer patients